Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up
Clinical trial NCT05316077 · UNKNOWN
Trial details
- NCT number
- NCT05316077
- Sponsor
- Guerbet
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.